Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LAMB2P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
RNASEH2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DOCK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AVPR1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POU6F1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STXBP5L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP295 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EDA2R - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
MED12L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSD17B12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAPN10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCUN1D1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TXNDC8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBMS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUTM2B-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on